InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Browse the detailed record of transactions filed by Lucera Erick, Chief Financial Officer. Insider active across 1 companies, notably Dyne Therapeutics, Inc.. Aggregated, 2 filings have been recorded. Total volume traded: €45k. The latest transaction was disclosed on 13 May 2026 — Cession. Regulator: SEC (Form 4). All data is accessible without signup.
Declarations2 total
€22,6911,448 shares@ €15.67080.0008% mcap50.0% of flow
Common Stock
SEC:0001193125-26-223961:0·
€22,6911,448 shares@ €15.67080.0008% mcap100.0% of flow
Common Stock
SEC:0001193125-26-223961·
2 of 2 declarations
About Lucera Erick
Erick Lucera serves as Chief Financial Officer of Dyne Therapeutics, Inc. He oversees the company's financial operations, including budgeting, financial analysis, and reporting. With a strong background in corporate finance, he plays a key role in Dyne Therapeutics' financial strategy. Erick Lucera is committed to ensuring financial transparency and supporting the company's sustainable growth.
